DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 141 filers reported holding DIPLOMAT PHARMACY INC in Q4 2019. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | -100.0% | 120 | -96.8% | 0.00% | – |
| Q3 2019 | $18,000 | -5.3% | 3,790 | +25.4% | 0.00% | – |
| Q2 2019 | $19,000 | +5.6% | 3,023 | 0.0% | 0.00% | – |
| Q1 2019 | $18,000 | -70.5% | 3,023 | -32.1% | 0.00% | -100.0% |
| Q4 2018 | $61,000 | -33.0% | 4,455 | -5.7% | 0.00% | 0.0% |
| Q3 2018 | $91,000 | -8.1% | 4,722 | +20.8% | 0.00% | 0.0% |
| Q2 2018 | $99,000 | +25.3% | 3,910 | -0.7% | 0.00% | 0.0% |
| Q1 2018 | $79,000 | -15.1% | 3,937 | -14.8% | 0.00% | 0.0% |
| Q4 2017 | $93,000 | +14.8% | 4,621 | +17.1% | 0.00% | 0.0% |
| Q3 2017 | $81,000 | +252.2% | 3,945 | +155.8% | 0.00% | – |
| Q2 2017 | $23,000 | +21.1% | 1,542 | +33.5% | 0.00% | – |
| Q1 2017 | $19,000 | -75.0% | 1,155 | -80.9% | 0.00% | -100.0% |
| Q4 2016 | $76,000 | -25.5% | 6,044 | +67.2% | 0.00% | 0.0% |
| Q3 2016 | $102,000 | -1.0% | 3,614 | +21.1% | 0.00% | -33.3% |
| Q2 2016 | $103,000 | – | 2,985 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empirical Capital Management, LLC | 452,018 | $11,554,000 | 10.87% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 195,126 | $4,987,000 | 1.90% |
| Capital Investment Advisory Services, LLC | 144,182 | $3,685,000 | 1.84% |
| Investors Research Corp | 95,150 | $2,432,000 | 1.41% |
| Redwood Investments, LLC | 783,983 | $20,039,000 | 1.38% |
| Cortina Asset Management, LLC | 1,085,078 | $27,735,000 | 1.30% |
| Pier Capital, LLC | 362,328 | $9,261,000 | 1.27% |
| Matarin Capital Management, LLC | 628,786 | $16,071,770,000 | 1.16% |
| BROADVIEW ADVISORS LLC | 264,800 | $6,768,000 | 1.08% |
| DARUMA CAPITAL MANAGEMENT LLC | 592,659 | $15,148,000 | 0.98% |